Insulin glargine is a long-acting type of insulin that works slowly, over about 24 hours. Insulin is one of many hormones that help the body turn the food we eat into energy. This is done by using the glucose (sugar) in the blood as quick energy. Also, insulin helps us store energy...
Insulin therapy is the mainstay of T1DM treatment, and glargine is long-acting insulin that is most commonly prescribed as a basal insulin therapy. Although glargine is typically administered once daily in the evening, alternative dosing frequencies and timings have been associated with promising ...
治疗类别 Alimentary Tract and Metabolism;Amino Acids, Peptides, and Proteins;Blood Glucose Lowering Agents;Drugs Used in Diabetes;Hormones;Hormones, Hormone Substitutes, and Hormone Antagonists;Hypoglycemia-Associated Agents;Insulin;Insulin Analog;Insulin, Long-Acting;Insulins and Analogues;Insulins and Ana...
Insulin glargine is a long-acting insulin used to treat type 2 diabetes and type 1 diabetes in certain patients to improve blood glucose levels. Includes Insulin glargine brands, uses side effects doses and interactions.
A10C5 (Human insulins and analogues, long-acting)(人体胰岛素及其类似物,长效) 首家研发企业 Aventis Pharma AG(赛诺菲) 研发企业 Aventis Pharma AG(赛诺菲)Sanofi SA(赛诺菲) 靶点 Insulin ligand(Insulin)全称:Insulin ligand(Insulin) 简称:Insulin
BASAGLAR® is a long-acting basal insulin used to control high blood sugar in adults and children with type 1 diabetes and adults with type 2 diabetes.
If changing from a treatment regimen with an intermediate- or long-acting insulin (other than an insulin glargine product, 100 units/mL) to a regimen with BASAGLAR, a change in the dose of the basal insulin may be required and the amount and timing of shorter-acting insulins and doses ...
serious and life-threatening.Severe hypoglycemia may cause harm to your heart or brain. Symptoms of serious low blood sugar may include shaking, sweating, fast heartbeat, and blurred vision. The long-acting effect of Toujeo may delay recovery from low blood sugar compared to shorter-acting ...
The article discusses the results of a clinical study examining the similarities between long-acting insulin analogs glargine (GLA) and detemir (DET) and their effects on glucose and lipid metabolisms in patients with type 1 diabetes mellitus (T1DM). It states that 21 patients underwent 24 hours...
[5]KirstineBrownFrandsen.LongactinginsulinAnalogues[J].SectionEndocrinolForeignMedsei,2004,24(7):15-16.[6]LivakKJ,SchmittgenTD.Analysisofrelativegeneexpressiondatausingreal-timequantitativePCRandthe2(-DeltaDeltaCT)[J].Method.Methods.2001Dec;25(4):402-8.[7]ZhangY,ProencaR,MaffeiM,etal.Positional...